Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 40021-40030 Newer>

The Motley Fool January 28, 2010 Colleen Paulson	Altria's Stayin' Alive Altria delivers EPS growth in spite of a decline in cigarette volume.
The Motley Fool January 28, 2010 Toby Shute	What's Not to Love About Noble? The contract driller's annual results show why the company's close to my heart.
The Motley Fool January 28, 2010 Brian Orelli	The Biggest Development-Stage Drugmaker, Ever Eli Lilly seems to have a lot more in common with its development-stage little brothers than it does with its big pharma brethren.
The Motley Fool January 28, 2010 Brian Orelli	Only the Strong Survive at Pfizer The culling of the pipeline isn't as bad as it sounds.
The Motley Fool January 28, 2010 Brian Orelli	The Next Amgen? Not Yet. Amylin Pharmaceuticals is in much the same situation as Amgen is in: relatively flat sales, and the potential for a nice boost from a Food and Drug Administration approval shortly. But that's where the comparison ends.
The Motley Fool January 28, 2010 Rick Aristotle Munarriz	Leave It to ETRADE It wasn't a great report, but ETRADE managed to at least match Wall Street's bottom-line expectations, posting a substantially smaller deficit than it did a year ago.
The Motley Fool January 28, 2010 Rich Smith	What in the World Is Goldman Sachs Thinking? Goldman's bullish on banks, while Hershey crashes from its sugar high.
The Motley Fool January 28, 2010 Mike Pienciak	Profit From These Consumer Trends in 2010 Consumer spending could lag the economy, even in a recovery.
The Motley Fool January 28, 2010 Toby Shute	Anadarko Makes Another Big Splash Anadarko is hitting home runs not only here at home, but offshore Brazil and West Africa as well.
The Motley Fool January 28, 2010 Jennifer Schonberger	Are We in the Midst of a Global Economic Recovery? An interview with Pankaj Khanna, the COO of DryShips.
<Older 40021-40030 Newer> Return to current articles.